VIRPAX PHARMACEUTICALS INC (VRPX) Stock Cash Flow
USA - NASDAQ:VRPX - US9282512063 - Common Stock
0.6695 USD
-0.55 (-45.12%)
0.4498 USD
-0.22 (-32.82%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.07M | -15.19M | -21.65M | -12.06M | -4.34M | |||
| Depreciation Amortization | null | null | null | null | null | |||
| Income Taxes - Deferred | null | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | -4.78M | 4.79M | 3.06M | -3.40M | 1.33M | |||
| Interest Paid | null | null | 0 | 362.80K | 0 | |||
| Taxes Paid | null | null | 0 | 0 | 0 | |||
| Other non cash items | 134.70K | 544.80K | 745.00K | 912.40K | 1.63M | |||
| OPERATING CASH FLOW | -16.71M | -9.85M | -17.85M | -14.54M | -1.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | null | null | null | null | null | |||
| Other Investing Activity | null | null | null | null | null | |||
| INVESTING CASH FLOW | null | null | null | null | null | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | null | null | 0 | -1.50M | 72.10K | |||
| Stock Issued/Repurchased | 9.08M | null | 0 | 58.02M | 1.38M | |||
| Dividend Paid | null | null | null | null | null | |||
| Other Financing Activity | null | null | 0 | -5.19M | -50.90K | |||
| FINANCING CASH FLOW | 9.08M | null | 0 | 51.33M | 1.40M | |||
| Exchange Rate Effect | null | null | null | null | null | |||
| CHANGE IN CASH | -7.63M | -9.85M | -17.85M | 36.79M | 13.30K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.71M | -9.85M | -17.85M | -14.54M | -1.38M | |||
| Capital Expenditure | null | null | null | null | null | |||
| FREE CASH FLOW | -16.71M | -9.85M | -17.85M | -14.54M | -1.38M | |||
All data in USD